Avalo Therapeutics Return on Net Operating Assets Analysis

Avalo Therapeutics, Inc. (AVTX)

16.37 +0.61 (+3.87%) USD | NASDAQ | Jan 22, 16:00

16.37 0.00 (0.00%) After-Hours: 20:00

View Return on Net Operating Assets for AVTX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Return on Net Operating Assets Chart

Start Trial

View Historical Data

Start Trial

View Return on Net Operating Assets Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Return on Net Operating Assets Benchmarks

Start Trial

Rocket Pharmaceuticals, Inc.	Upgrade
NovaBay Pharmaceuticals, Inc.	Upgrade
Palatin Technologies, Inc.	Upgrade
Theriva Biologics, Inc.	Upgrade
Oragenics, Inc.	Upgrade